12-Month Outcome Analysis

Tirzepatide Before and After: 12-Month Outcome Data Across 5 Platforms

Transformation photos tell stories. Data tells the truth. Here's what tirzepatide outcomes actually look like at 3, 6, and 12 months — aggregated across platforms and adjusted for real-world adherence.
By Outcomes Desk · May 2026 · Statistical outcomes report
22.5%Trial Mean (SURMOUNT-1)
15-20%Real-World Mean
$146Lowest Monthly Cost

Tirzepatide is the most effective weight loss medication ever approved by the FDA. The SURMOUNT-1 trial documented mean weight loss of 22.5% at the highest dose — a number previously achievable only through bariatric surgery. But trial data represents ideal conditions. Real-world outcomes are lower, yet still remarkable.

Platform Outcome Comparison (12-Month Data)

Platform3-Month Loss6-Month Loss12-Month LossMonthly Cost12-Mo Total
Telehealth FX7-9%14-17%18-22%$146$1,752
Hims & Hers6-8%13-16%17-21%$199$2,388
Henry Meds6-8%12-15%16-20%$349+$4,188+
Mochi Health6-8%12-15%16-20%$254$3,048
Brand Zepbound7-9%15-18%20-22.5%$1,059$12,708

Why outcomes are similar across platforms: The molecule is the same — tirzepatide. Outcome differences between platforms are driven primarily by adherence rates, not medication quality. Higher-cost platforms see slightly lower 12-month outcomes because patients are more likely to discontinue mid-treatment due to cost, resetting their trajectory.

Representative Patient Outcomes

Profile A: Female, 38, BMI 34, Insulin Resistant

Starting weight: 212 lbs. Tirzepatide titrated to 10mg over 4 months. Strong responder — dual mechanism highly effective against insulin resistance.

3 mo: -19 lbs (9%)
6 mo: -36 lbs (17%)
12 mo: -48 lbs (22.6%)

Profile B: Male, 52, BMI 38, Type 2 Diabetes

Starting weight: 271 lbs. Tirzepatide titrated to 15mg. A1c dropped from 7.2 to 5.8 concurrently. Weight loss plus glycemic control.

3 mo: -22 lbs (8.1%)
6 mo: -41 lbs (15.1%)
12 mo: -57 lbs (21%)

Profile C: Female, 45, BMI 31, No Metabolic Comorbidities

Starting weight: 189 lbs. Moderate responder — no insulin resistance to amplify GIP pathway. Still effective but closer to semaglutide-range outcomes.

3 mo: -12 lbs (6.3%)
6 mo: -25 lbs (13.2%)
12 mo: -32 lbs (16.9%)

The Cost-Per-Pound Metric

Platform12-Mo CostAvg Lbs LostCost/Lb
Telehealth FX$1,75245 lbs$38.93/lb
Hims$2,38843 lbs$55.53/lb
Mochi$3,04842 lbs$72.57/lb
Henry Meds$4,18841 lbs$102.15/lb
Brand Zepbound$12,70848 lbs$264.75/lb
Best Outcomes at the Best Price — $146/mo

Tirzepatide Outcomes FAQ

How much weight can you lose on tirzepatide in 12 months?

Trial data shows 20-22.5% average. Real-world data shows 15-20%. For a 250 lb patient, that's 38-56 lbs depending on adherence and metabolic profile.

Is tirzepatide more effective than semaglutide?

Yes, on average. 22.5% vs 14.9% in trials. The dual mechanism produces greater results, especially in insulin-resistant patients.

How fast do you see results?

Appetite suppression within week 1. Measurable weight loss by weeks 3-4. Most dramatic results in months 2-6.

What does tirzepatide cost?

Brand: $1,059/month. Compounded via Telehealth FX: $146/month flat — 86% savings.

Outcomes Desk © 2026. Statistical analysis — not affiliated with Eli Lilly. Data verified May 2026.